Ireland
--:--IST
Latest
Clinical Trials in Italy / NCT06641973
Starting soon Not applicable

Technological Balance Rehabilitation in Feed and Eating Disorders

NCT06641973 · tracked via the Priya Life Science Italy tracker
Phase
Not applicable
Started
2025-09
Last updated
2025-07-14

Condition(s) studied

Feeding DisordersAnorexia NervosaBulimia Nervosa

Investigational drug(s) / intervention(s)

Robotic balance rehabilitation with hunova® robotic platform

Robotic balance rehabilitation with hunova® robotic platform: The G-Hun will perform robotic balance treatment with the hunova® robotic platform lasting 30 minutes per session, 2 times a week for 5 weeks, in addition to the services provided in their clinical pathway.

Study summary

Postural control depends on the central integration of vestibular, visual, and somatosensory inputs and the integrity of the neural efferent motor pathway, which continuously provides postural adjustments to environmental and body position changes. It is considered a complex skill and involves the integration of movement strategies necessary for maintaining balance. Decreased postural control can induce instabilities that affect the performance of daily activities and increase the risk of falls. Decreased postural control can be linked to fluctuations in body weight: significant weight gain or loss, in fact, can induce musculoskeletal adaptations , which contribute to postural and motor alterations . In Italy, approximately 3 million people are affected by Feed and Eating Disorders (FED), which include, among others, anorexia nervosa (AN), bulimia nervosa (BN) and uncontrolled eating disorder (UED). There are works in the literature highlighting that both anorexic and obese patients present with impaired postural control and, consequently, reduced balance.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Age between 18 and 65 years; * Diagnosis of AN, BN, DAI according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders-5 Edition, DSM-5) * Ability to walk independently or with little assistance; * Ability to understand and sign informed consent. Exclusion Criteria: * Current or past cognitive disorders (mental retardation) with Mini Mental State Evaluation (MMSE) values ≤ 26 ; * Severe clinical conditions (head trauma, severe neurological and cardiac diseases and vascular disorders, oncological diseases); * Substance use disorders; * Unstabilized major psychiatric disorders (e.g., manic episode, acute psychotic episode, etc.); * Taking medications that alter cardiac activity; * Orthopedic or postural problems; * Presence of plantar ulcers; * Partial or total amputation of foot segments; * Inability to provide informed consent.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Fondazione Policlinico Universitario A. Gemelli IRCCS Roma Roma

More Fondazione Policlinico Universitario Agostino Gemelli IRCCS trials in Italy

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06641973 on ClinicalTrials.gov ↗ ← All trials in Italy